Global Onychomycosis Treatment Market Share

Market Share of Global Onychomycosis Treatment Industry

The onychomycosis treatment market is fragmented and competitive and consists of several major players. Companies are focusing on developments, collaborations, and product launches to strengthen their market position. For instance, in April 2020, the US Food and Drug Administration expanded the approval of Jublia manufactured by Bausch Health. Jublia is a topical solution used to treat onychomycosis in the toenail(s) in patients aged six years and above.

Some of the players currently dominating the market are Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.), Galderma SA, Novartis AG, Pfizer Inc., Moberg Pharma AB, Johnson & Johnson, Bayer AG, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Medimetriks Pharmaceuticals Inc., and Lumenis Ltd.

Onychomycosis Treatment Market Leaders

1. Bausch Health Companies Inc (Valeant Pharmaceuticals Inc)

2. Galderma S.A.

3. Novartis AG

4. Pfizer, Inc

5. Moberg Pharma AB

*Disclaimer: Major Players sorted in no particular order